One-year results of 0.01% atropine with orthokeratology (AOK) study: a randomised clinical trial.
Qi TanAlex Lk NgBonnie Nk ChoyGeorge Pm ChengVictor Cp WooPauline ChoPublished in: Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists) (2020)
There is an additive effect between 0.01% atropine and ortho-k over one year, with mean axial elongation in the AOK group 0.09 mm slower than that in the OK group. It appears that the additive effect was only during the first six months; a second-year investigation is warranted to determine whether the effect is sustained over time.